c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Maravai LifeSciences (MRVI) Raises FY26 Adjusted EBITDA Guidance Amid Revenue Growth Expectations
GuruFocus | Nov 4, 2026 4:25 PM EST
Related Stocks: MRVI ,
Read original article